Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Supercontinuum Fiber Lasers

Facebook Twitter LinkedIn Email Comments
SOUTHAMPTON, UK and EUGENE, Ore. Oct. 14, 2008 – A consortium led by ultrafast fiber laser manufacturer Fianium Ltd., is to develop and evaluate advanced white-light (supercontinuum) fiber lasers for biomedical imaging applications.

The $3.6 million "WhiteLase" project is co-funded by the UK Technology Strategy Board and brings together Fianium, the Centre for Photonics and Photonic Materials (CPPM) at the University of Bath and Edinburgh Instruments Ltd.

The project aims to deliver UV-content supercontinuum sources and ultrabright visible supercontinuum sources and evaluate the technology within fluorescence imaging applications.

The new lasers will offer UV content down to below 300nm and provide spectral power densities an order of magnitude higher than those of existing, commercial supercontinuum sources.

“This award is a clear recognition of our achievements at the forefront of supercontinuum fiber laser technology,” said John Clowes, director of business development at Fianium and coordinator of the WhiteLase project. “Fianium's past collaboration with the CPPM at the University of Bath has been extremely successful and will be a great benefit in developing revolutionary new white light fiber lasers for biomedical imaging applications."

William Wadsworth, who leads the CPPM team added, "The CPPM has a long and distinguished history in supercontinuum generation and the challenging objectives of the WhiteLase project will undoubtedly lead us to exciting new developments in photonic crystal fibers."

"We are committed to stimulating the development and deployment of technologies which, as well as benefiting society, also represent major business opportunities for the UK,” said Mike Biddle, a technologist for photonics, explaining the Technology Strategy Board's support for the WhiteLase project. “This project brings together the UK's world class expertise to research and develop an innovative technology that could be exploited globally. We are delighted to offer our support and investment to Fianium and their partners in this important project."

As end-user partners within the project, Edinburgh Instruments is gaining first access to the newly-developed supercontinuum fiber lasers and evaluating these sources in a host of fluorescence imaging applications.

"Fianium is also working with several industrial partners in the US and government laboratories on developing applications of supercontinuum systems. Most of these applications require operation across UV spectral range, making the project very relevant to many of our customers," added Vladimir Kozlov, vice president of business development at Fianium Ltd.

For more information, visit:
Oct 2008
The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
below 300nmbiomedical imaging applicationsBiophotonicsEdinburgh Instruments Ltd.Fianium Ltd.fiber lasersfluorescence imagingindustrialJohn ClowesMike BiddleNews & FeaturesphotonicssupercontinuumUK Technology Strategy BoardUniversity of BathUV-content supercontinuumVladimir KozlovWhiteLaseWilliam Wadsworth

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.